India in talks to join COVAX vaccine allocation scheme, says WHO official

The WHO and the GAVI vaccine alliance are leading the COVAX facility, aimed at helping buy and distribute vaccination shots against the novel coronavirus fairly around the world

WHO
The United States played a pivotal role in helping to create the WHO in 1948. Just over 70 years later, President Trump is withdrawing the country from the agency amid the COVID-19 pandemic. Martial Trezzini/EPA
Reuters Geneva
1 min read Last Updated : Sep 07 2020 | 11:01 PM IST
The World Health Organization is in talks with India about joining the "COVAX" global vaccine allocation plan, a senior WHO adviser said on Monday.

"India is certainly eligible, like all countries in the world, to be part of the COVAX facility and discussions are ongoing in that regard," Bruce Aylward told a briefing in Geneva. "We would welcome Indian participation ...India has extensive experience (with vaccines)."

The WHO and the GAVI vaccine alliance are leading the COVAX facility, aimed at helping buy and distribute vaccination shots against the novel coronavirus fairly around the world. But some countries that have secured their own supplies through bilateral deals, including the United States, have said they will not join COVAX.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus Vaccine

Next Story